Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

Value Health. 2014 Nov;17(7):A679. doi: 10.1016/j.jval.2014.08.2529. Epub 2014 Oct 26.

Authors

R Stetka¹, M Psenkova², M Ondrusova², L Hlavinkova³, P Trnovec³

Affiliations

¹ Pharm-In, Ltd, Bratislava, Slovak Republic.
² Pharm-In Ltd, Bratislava, Slovak Republic.
³ GlaxoSmithKline Slovakia, Bratislava, Slovak Republic.

PMID: 27202506
DOI: 10.1016/j.jval.2014.08.2529

No abstract available